Volumetric MRI for evaluation of regional pattern and progression of neocortical degeneration in Alzheimer's disease;MR-volumetrie zur darstellung von verteilung und zeitlicher abfolge neokortikaler degeneration bei morbus Alzheimer

Radiologe

Volumn 43, Issue 7, 2003, Pages 537-542

  Leinsinger, G ^a   Teipel, S ^b   Wismuller A ^a   Born, C ^a   Meindl, T ^a   Flatz, W ^a   Schonberg S ^a   Pruessner, J ^b   Hampel, H ^b   Reiser, M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Alzheimer's disease; Corpus callosum; Hippocampus; MRI; Neocortex

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BRAIN ATROPHY; BRAIN REGION; CORPUS CALLOSUM; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; NEOCORTEX; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; VOLUMETRY;

ALZHEIMER DISEASE; AMYGDALA; ATROPHY; CLINICAL TRIALS; CORPUS CALLOSUM; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; NEOCORTEX; ROC CURVE; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0041622803     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-003-0928-1     Document Type: Article

References (31)

1. DeCarli C (2001) The role of neuroimaging in dementia. Clin Geriatr Med 17/2: 255-279
2. Jack CR, Petersen RC, Xu YC et al. (1999) Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52: 1397-1403
3. Krasuski RJ, Alexander GE, Horwitz B et al. (1998) Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol Psychiatry 43: 60-68
4. Pearlson GD, Harris GJ, Powers RE et al. (1992) Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry 49: 402-408
5. Seab JP, Jagust WJ, Wong STS et al. (1988) Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med 8: 200-208
6. Killiany RJ, Hyman BT, Gomez-Isla T et al. (2002) MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 58: 1188-1196
7. De Toledo-Morrell L, Goncharova I, Dickerson B, Wilson RS, Bennett DA (2000) From healthy aging to early Alzheimer's disease: in vivo detection of entorhinal cortex atrophy. Ann NY Acad Sci 911: 240-253
8. Xu Y, Jack CR, O'Brian PC et al. (2000) Usefulness of MRI measures of entorhinal cortex vs. hippocampus in AD. Neurology 54: 1760-1767
9. Yamauchi H, Fukuyama H, Nagahama Y et al. (2000) Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease. J Neurol Neurosurg Psychiatry 69: 623-629
10. Pantel J, Schröder J, Essig M et al. (1998) Corpus callosum in Alzheimer's disease and vascular dementia - a quantitative magnetic resonance study. J Neural Transm 54 (Suppl): 129-136
11. Janowsky JS, Kaye JA, Carper RA (1996) Atrophy of the corpus callosum in Alzheimer's disease vs. healthy aging. J Am Geriatr Soc 44: 798-803
12. Hanyu H, Asano T, Sakurai H et al. (2002) MR analysis of the substantia innominata in normal aging, Alzheimer disease,and other types of dementia. Am J Neuroradiol 23/1: 27-32
13. Murphy DGM, DeCarli CD, Daly E et al. (1993) Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: correlations with disease severity. Biol Psychiatry 34: 612-621
14. Tanna NK, Kohn MI, Horwich DN et al. (1991) Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET Data correction. Radiology 178: 123-130
15. Baron JC, Chetelat G, Desgranges B et al. (2001) In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 14/2: 298-309
16. Fox NC, Crum WR, Scahill RI et al. (2001) Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images. Lancet 358/9277: 201-205
17. Thompson PM, Mega MS, Woods RP et al. (2001) Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb Cortex 11: 1-16
18. Hampel H, Teipel SJ, Alexander GE et al. (1998) Corpus callosum atrophy is a possible indicator for region and cell type specific neuronal degeneration in Alzheimer disease: An MRI analysis. Arch Neurol 55: 193-198
19. Hampel H, Teipel SJ, Alexander GE et al. (2002) In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. J Neural Transm 109: 837-855
20. Pruessner JC, Koehler S, Crane J et al. (2002) Volumetry of temporopolar, perirhinal, entorhinal, and parahippocampal cortex from high-resolution MR images: considering the variability of the collateral sulcus. Cerebral Cortex 12: 1342-1353
21. Teipel SJ, Bayer W, Alexander GE et al. (2002) Progression of corpus callosum atrophy in Alzheimer disease. Arch Neurol 59: 243-248
22. Teipel SJ, Bayer W, Alexander GE et al. (2003) Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration. Neurobiol Aging 24: 85-94
23. Bokde AL, Teipel SJ, Zebuhr Y et al. (2002) A new rapid landmark-based regional MRI segmentation method of the brain. J Neurol Sci 194: 35-40
24. Scheltens P, Barkhof F, Leys D et al. (1993) A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114: 7-12
25. Teipel SJ, Hampel H, Alexander GE et al. (1998) Dissociation between white matter pathology and corpus callosum atrophy in Alzheimer's disease. Neurology 51: 1381-1385.
26. Hampel H, Teipel SJ, Alexander GE et al. (2000) Corpus callosum measurement is an in vivo indicator for neocortical neuronal integrity, but not white matter pathology, in Alzheimer's disease. Ann NY Acad Sci 903: 470-477
27. Teipel SJ, Hampel H, Pietrini P et al. (1999) Region specific corpus callosum atrophy correlates with regional pattern of cortical glucose metabolism in Alzheimer's disease. Arch Neurol 56: 467-473
28. Hanley JA, McNeil BJ (1983) A method ofcomparing the areas under receiver operating characteristics curves derived from the same cases. Radiology 148: 839-843
29. Pogarell O, Teipel SJ, Juckel G et al. (2003) Decline of interhemispheric EEG coherence reflects regional corpus callosum atrophy in patients with Alzheimer's disease. (submitted)
30. Braak H, Griffing K, Braak E (1997) Neuroanatomy of Alzheimer's disease. Alzheimer's Res 3: 235-247
31. Duara R, Grady C, Haxby J et al. (1986) Positron emission tomography in Alzheimer's disease. Neurology 36: 879-887